BioSpace News Archive

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that a team of globally renowned researchers utilized two NanoString platforms, the nCounter® Analysis System and GeoMx® Digital Spatial Profiler, to decode the immune response following the transplantation of genetically modified pig kidneys into humans.

Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, announced that Dan L. Dearen, president and chief financial officer, is retiring from the company.

Johnson & Johnson announced that, based on preliminary results, its previously announced offer to its shareholders to exchange their shares of Johnson & Johnson common stock for shares of Kenvue Inc. common stock owned by Johnson & Johnson was oversubscribed.

Axogen, Inc. today announced the successful first week of processing for Avance Nerve Graft at the newly opened Axogen Processing Center (APC), in Dayton, Ohio.

Amicus Therapeutics today announced that Simon Harford has been appointed Chief Financial Officer, effective immediately.

Applied UV, Inc. today announced its financial results for the second quarter 2022.

Actinium Pharmaceuticals, Inc. today details two abstracts accepted for oral and poster presentation at the upcoming European Association of Nuclear Medicine (EANM) 2023 Congress, which will be held in Vienna, September 9-13, 2023.

Apogee Therapeutics, Inc. today announced the appointment of Mark C. McKenna as Chairman of its board of directors.

Genesis Therapeutics, a company pioneering artificial intelligence (AI) technologies to create breakthrough medicines for patients with severe diseases, announced today that it has closed an oversubscribed $200 million round of Series B financing.

Anebulo Pharmaceuticals, Inc. today announced positive feedback from the United States Food and Drug Administration (FDA) following a Type B meeting in July.